Interferon Current Events | Interferon News | 6
|
| Page
6 of
6 |
119 Results |
|
|
|
Sort By:
Page Views | Date |
First clinical trial of intravenous rViscumin under way in Germany and France
Frankfurt, Germany: More than 30 patients in Germany and France with a variety of drug resistant cancers have so far been recruited to a phase I study of rViscumin, a recombinant E.coli-derived protein with a structural similarity to mistletoe lectin I - a component of natural mistletoe extracts from Viscum album. But, a news briefing (Thursday... view more... (2002-11-17)
Drug that battles resistance to leukemia pill Gleevec 'extremely effective' against cancer
An experimental therapy that battles drug resistance in Chronic Myeloid Leukemia (CML) has proved "extremely effective" in fighting cancer, giving patients for whom all conventional therapies have failed another option. view more (2006-06-15)
Clearance of hepatitis C viral infection after liver transplantation
Touching stories of living donor transplantation are continuously happening in hospitals. One of these stories is reported recently in the August 14 issue of the World Journal of Gastroenterology because of its shining significance in hepatology. view more (2007-08-29)
Targeted therapy shows significant benefits over standard treatment for advanced kidney cancer
According to a new study, the drug sunitinib malate (Sutent®) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC). view more (2006-06-05)
UT Southwestern researchers refocus studies on patients with HIV, hepatitis
As HIV patients live longer thanks to advanced therapies, researchers are looking for better ways to treat accompanying maladies such as hepatitis that traditionally were not emphasized. view more (2006-10-12)
Protecting babies from RSV could reduce the chances of wheeze and asthma during childhood
Researchers from Imperial College London and St Mary’s NHS Trust have discovered that keeping people with coughs and sneezes away from young babies may cut the likelihood of developing wheeze or asthma later in childhood. view more (2002-11-14)
NEJM editorial on significance and limitations of new lupus gene expression research
Some 1.5 million Americans, most of them women, suffer from lupus, a disease where the person's immune system attacks the body's own tissue. view more (2008-01-21)
Healthy human immune system cells can respond to HIV-1
AIDS patients' failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought. view more (2006-05-18)
New therapy prevents dangerous side effect for lymphoma patients
Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
Hepatitis B patients' understanding of infection and treatment deficient
Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem. view more (2007-05-29)
New insights into the regulation of PTEN tumor suppression function
The PTEN tumor suppressor gene controls numerous biological processes including cell proliferation, cell growth and death. But PTEN is frequently lost or mutated; in fact, alteration of the gene is so common among various types of human cancer that PTEN has become one of the most frequently mutated of all tumor suppressors. view more (2008-08-21)
Weight loss after gastric bypass surgery may protect against infection and cancer
Another health benefit of bariatric weight-loss surgery may be a heightened immune defense against cancer and infections, a new study suggests. The results will be presented at The Endocrine Society's 90th Annual Meeting in San Francisco. view more (2008-06-18)
Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells
An international team of researchers has identified a new method for selectively killing metastatic melanoma cells, which may lead to new areas for drug development in melanoma - a cancer that is highly resistant to current treatment strategies. view more (2009-08-04)
Research team develops cancer-curing T-lymphocyte-based therapy to eradicate malignant tumours
Research in Immunology and Cancer (IRIC) of the Université de Montréal, has succeeded in developing a new approach to eradicate malignant melanoma tumours in mice. view more (2005-10-19)
University of Kent signs licensing deal with Delta Biotechnology Limited
The University of Kent has recently concluded negotiations with Delta Biotechnology - a company with more than twenty years experience in the expression of heterologous proteins - to allow licensing of the technology covered by the University's patent process for increasing the production of disulphide bonded recombinant proteins from the baker's... view more... (2004-02-05)
Finding a cure for cancer: the holy grail of science
To find a cure for cancer, the modern-day plague of our society - is synonymous to finding the holy grail of science. view more (2006-11-22)
Can liver cirrhosis be partially cured?
The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs. view more (2007-10-11)
Advances in HBV DNA assays are key to determine best long-term treatment strategies for Hepatitis B
For the 350 million people chronically infected with HBV, the two therapeutic approaches currently available are immunomodulatory agents and antiviral chemotherapy. The first therapeutic agent was interferon-alpha (IFN-alpha), whose dual mode of action includes both antiviral and immunomodulatory effects. Unfortunately, extended IFN-alpha... view more... (2005-01-10)
Researchers find 'secret weapon' used by SARS virus
In 2003, the highly contagious and often-deadly mystery disease now called SARS emerged explosively out of Southern China. It eventually killed an estimated 916 people in Asia, Europe, and North and South America-nearly one in ten of those it infected. view more (2006-08-08)
|
|
| Page
6 of
6 |
119 Results |
|
|
|
Sort By:
Page Views | Date |
|
